EP1117835A4 - Prevention of adhesions - Google Patents

Prevention of adhesions

Info

Publication number
EP1117835A4
EP1117835A4 EP99950135A EP99950135A EP1117835A4 EP 1117835 A4 EP1117835 A4 EP 1117835A4 EP 99950135 A EP99950135 A EP 99950135A EP 99950135 A EP99950135 A EP 99950135A EP 1117835 A4 EP1117835 A4 EP 1117835A4
Authority
EP
European Patent Office
Prior art keywords
adhesions
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99950135A
Other languages
German (de)
French (fr)
Other versions
EP1117835A1 (en
Inventor
Nasser Chegini
James Burns
Michael Diamond
Lena Holmdahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
University of Florida
Original Assignee
Genzyme Corp
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, University of Florida filed Critical Genzyme Corp
Publication of EP1117835A1 publication Critical patent/EP1117835A1/en
Publication of EP1117835A4 publication Critical patent/EP1117835A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP99950135A 1998-10-02 1999-10-01 Prevention of adhesions Withdrawn EP1117835A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10286998P 1998-10-02 1998-10-02
US102869P 1998-10-02
PCT/US1999/023014 WO2000020642A1 (en) 1998-10-02 1999-10-01 Prevention of adhesions

Publications (2)

Publication Number Publication Date
EP1117835A1 EP1117835A1 (en) 2001-07-25
EP1117835A4 true EP1117835A4 (en) 2005-03-09

Family

ID=22292085

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99950135A Withdrawn EP1117835A4 (en) 1998-10-02 1999-10-01 Prevention of adhesions

Country Status (5)

Country Link
EP (1) EP1117835A4 (en)
JP (1) JP2002526556A (en)
AU (1) AU6285999A (en)
CA (1) CA2354863A1 (en)
WO (1) WO2000020642A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036915T2 (en) 1999-01-13 2008-08-07 Alchemia Oncology Pty Ltd., Hawthorn USE OF HYALURONAN FOR THE MANUFACTURE OF A MEDICAMENT FOR INCREASING THE EFFICACY OF CYTOTOXIC DRUGS
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US6518308B2 (en) 2000-11-21 2003-02-11 Michael P. Diamond Compositions for adhesion prevention
DE60237969D1 (en) 2001-04-24 2010-11-25 Bayer Corp HUMAN ANTIBODIES AGAINST TIMP-1
US6812220B2 (en) * 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
JP5465431B2 (en) 2005-07-27 2014-04-09 アルケミア オンコロジー ピーティーワイ リミテッド Treatment protocol with hyaluronan
US8623354B2 (en) * 2005-09-07 2014-01-07 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744442A (en) * 1992-08-26 1998-04-28 Bristol Meyers Squibb Company Regulation of cellular invasiveness
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAWASHIMA Y ET AL: "Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues.", CURRENT EYE RESEARCH. APR 1998, vol. 17, no. 4, April 1998 (1998-04-01), pages 445 - 451, XP008041356, ISSN: 0271-3683 *
See also references of WO0020642A1 *

Also Published As

Publication number Publication date
CA2354863A1 (en) 2000-04-13
WO2000020642A1 (en) 2000-04-13
AU6285999A (en) 2000-04-26
JP2002526556A (en) 2002-08-20
EP1117835A1 (en) 2001-07-25

Similar Documents

Publication Publication Date Title
GB9800795D0 (en) Prevention of multiple use of limited use devices
AU5100599A (en) Egf-genistein for prevention of restenosis
GB9813906D0 (en) Coatings
IL124403A0 (en) Blast protection of curtain walls
EP1071416A4 (en) Inhibition of gram positive bacteria
HUP0104410A3 (en) A composition for the prevention and/or treatment of atherosclerosis
EP1117835A4 (en) Prevention of adhesions
PL342733A1 (en) Biocement of improved properties
GB9816214D0 (en) Deactivator
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB9823690D0 (en) Facilitating ablutions
GB2353037B (en) Modification of polymers
AU2964199A (en) Prevention and treatment of adhesions
GB9810127D0 (en) Prevention of surgical adhesions
GB9800616D0 (en) Corrosion protector
GB0015035D0 (en) Prevention of adhesions
GB2342600B (en) Coatings
GB9809889D0 (en) Prevention of restenosis
EP1005340A4 (en) Retinoid antagonists for prevention of surgical adhesions
GB0001352D0 (en) Prevention of adhesions
GB9819137D0 (en) Component of bromelain
TW400927U (en) Improvement of screw
TW354479U (en) Improvement of earpick
GB9828194D0 (en) Wall
HU9800600D0 (en) Plan against attack of car-drivers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20050121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050801